Porter JB - Search Results

1

Porter JB. Porter JB. Br J Haematol. 2001 Nov;115(2):239-52. doi: 10.1046/j.1365-2141.2001.03195.x. Br J Haematol. 2001. PMID: 11703317 Review. No abstract available.

2

Quantification of desferrioxamine and its iron chelating metabolites by high-performance liquid chromatography and simultaneous ultraviolet-visible/radioactive detection.

Singh S, Mohammed N, Ackerman R, Porter JB, Hider RC. Singh S, et al. Among authors: porter jb. Anal Biochem. 1992 May 15;203(1):116-20. doi: 10.1016/0003-2697(92)90050-h. Anal Biochem. 1992. PMID: 1524206

3

Comparison of the subacute toxicity and efficacy of 3-hydroxypyridin-4-one iron chelators in overloaded and nonoverloaded mice.

Porter JB, Hoyes KP, Abeysinghe RD, Brooks PN, Huehns ER, Hider RC. Porter JB, et al. Blood. 1991 Nov 15;78(10):2727-34. Blood. 1991. PMID: 1824264 Free article.

4

Separation and identification of desferrioxamine and its iron chelating metabolites by high-performance liquid chromatography and fast atom bombardment mass spectrometry: choice of complexing agent and application to biological fluids.

Singh S, Hider RC, Porter JB. Singh S, et al. Among authors: porter jb. Anal Biochem. 1990 Jun;187(2):212-9. doi: 10.1016/0003-2697(90)90446-g. Anal Biochem. 1990. PMID: 2116739

5

Secretion of neutrophil secondary granules occurs during granulocyte-macrophage colony stimulating factor induced margination.

Devereux S, Porter JB, Hoyes KP, Abeysinghe RD, Saib R, Linch DC. Devereux S, et al. Among authors: porter jb. Br J Haematol. 1990 Jan;74(1):17-23. doi: 10.1111/j.1365-2141.1990.tb02532.x. Br J Haematol. 1990. PMID: 2178671

6

Update on the hydroxypyridinone oral iron-chelating agents.

Porter JB, Hider RC, Huehns ER. Porter JB, et al. Semin Hematol. 1990 Apr;27(2):95-100. Semin Hematol. 1990. PMID: 2190323 Review. No abstract available.

7

Relative oral efficacy and acute toxicity of hydroxypyridin-4-one iron chelators in mice.

Porter JB, Morgan J, Hoyes KP, Burke LC, Huehns ER, Hider RC. Porter JB, et al. Blood. 1990 Dec 1;76(11):2389-96. Blood. 1990. PMID: 2257308 Free article.

8

A direct method for quantification of non-transferrin-bound iron.

Singh S, Hider RC, Porter JB. Singh S, et al. Among authors: porter jb. Anal Biochem. 1990 May 1;186(2):320-3. doi: 10.1016/0003-2697(90)90088-q. Anal Biochem. 1990. PMID: 2363505

9

Desferrioxamine ototoxicity: evaluation of risk factors in thalassaemic patients and guidelines for safe dosage.

Porter JB, Jaswon MS, Huehns ER, East CA, Hazell JW. Porter JB, et al. Br J Haematol. 1989 Nov;73(3):403-9. doi: 10.1111/j.1365-2141.1989.tb07761.x. Br J Haematol. 1989. PMID: 2605127

10

The development of iron chelating drugs.

Porter JB, Huehns ER, Hider RC. Porter JB, et al. Baillieres Clin Haematol. 1989 Apr;2(2):257-92. doi: 10.1016/s0950-3536(89)80018-6. Baillieres Clin Haematol. 1989. PMID: 2660929 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results